
Laurus Labs Q3 net slides 43% as ARV sales drag
The Hindu
Drugmaker post ₹154.97 cr consolidated net profit
Drugmaker Laurus Labs reported a more than 43% decline in consolidated net profit to ₹154.97 crore for the quarter ended December 31, 2021.
The lower net profit, compared with the ₹272.85 crore seen a year earlier, came on the back of total income of ₹1,034.09 crore (₹1,295.35 crore). The company attributed the 20% decline in income to the transient inventory correction of the anti-retroviral (ARV) business.
Core results continued to remain resilient with strong growth in synthesis and other APIs, Laurus said in a release. CEO Satyanarayana Chava said lower sales of ARV APIs and formulations due to stocking at channel partners had affected Q3 results.

Thousand Lights MLA from the DMK N. Ezhilan, in an interview to The Hindu, observes that any popular personality entering politics will attract the limelight. But only a structured party machinery combined with popularity can ensure success. In this interview, he speaks about his tenure as first-time MLA from Thousand Lights Assembly constituency in Chennai, Vijay’s political entry shaping the 2026 elections, redressal of key grievances and more.

Against the backdrop of intense poll activity, a 400-metre stretch of an arterial road in the outskirts of Chennai (technically in Madurapakkam panchayat under Tambaram assembly constituency) presents a salute to the idea of res publica, which underpins India’s system of governance, where citizens have a say, at least before a government is securely ensconced in the seat of power. A Republic Day initiative shines bright every night

Set to unfold as a one-day pop-up on April 5, the Easter Sadya brings together both vegetarian and non-vegetarian menus, offering a peek into the food traditions of the Syrian Christian (Nasrani) community. While the traditional Sadya is often associated with dishes such as sambar, avial, and rice, this version expands to include community-specific festive dishes.










